Trillium Therapeutics to Report Preclinical Data on TTI-621 and TTI-622 at the AACR Annual Meeting 2018

NEXT STORY
Active Biotech’s partner NeoTX presents new data at AACR demonstrating that ANYARA enhances the efficacy of checkpoint blockade in preclinical models of cancer
PREV STORY
Advancement in Diagnostic Technology Driving the Growth of Point of Care Diagnostics Market, to Grow at a CAGR of 8.87% during 2018 – 2024: Energias Market Research Pvt. Ltd.
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sanofi to invest in a leading-edge production site in Singapore; continues to strengthen its vaccines manufacturing capacities

author_avatar
NASDAQ Market News

Norton Healthcare enrolls first patient in world for COVID-19 drug trial

author_avatar
NASDAQ Market News

Aprea Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Update on Business Operations

author_avatar
NASDAQ Market News